Confirming the role of Fbln7 in cancers, de Vega et al. recently showed that Fbln7 is over-expressed by the glioblastoma tissue among astrocytic tumors, where it was primarily localized in the endothelial cells and pericytes of the glomeruloid and hypertrophied microvessels (de Vega et al. 2019). Here, FBLN7 is linked to glioblastoma.